Posted on

how to use cbd cream for neuropathy

CBD doses can be as low as 5 mg, but some people ingest as many as 100 mg of CBD oil per day. The effects of the oil can be felt in as little as 20 minutes, depending on the size of the dosage you take. Again, speak with your primary physician about CBD and ask for a recommended dosage to treat your underlying physical symptoms.

The endocannabinoid system is capable of controlling, and often suppressing pain within the human body. The endocannabinoid system naturally motions enzymes throughout the body until they attach themselves to neurotransmitters. Once the enzymes are connected to the neurotransmitters, signals are sent to the brain that helps to reduce the effects of physical pain or psychological trauma.

Inflammatory conditions like diabetes that cause nerve or tissue damage are combated by the endocannabinoid system. Endocannabinoids attach themselves to neurotransmitters that, in turn, help to treat or prevent the intense physical pain caused by inflammatory symptoms.

How to treat neuropathy naturally

Neuropathic pain control is the body’s way of dealing with symptoms of neuropathy, and the endocannabinoid system has been identified by scientists as a neurotransmitter system that can help to manage neuropathic pain. The neurons and immune cells that comprise the endocannabinoid system relieve physical agony in select areas of the body.

An intense burning pain is a diagnosable symptom of peripheral neuropathy. According to the Mayo Clinic, the condition is frequently caused by injuries, infections, metabolic problems, or an inherited physical disability.

CBD oil is an anti-inflammatory remedy that helps heal nerves within the body. CBD has helped several patients with diabetes live more fulfilling, pain-free lives.

There exists a close relationship between CBD oil and the endocannabinoid system. How do the two co-exist? Let’s look into that.

Methods: In total, 29 patients with symptomatic peripheral neuropathy were recruited and enrolled. 15 patients were randomized to the CBD group with the treatment product containing 250 mg CBD/3 fl. oz, and 14 patients were randomized to the placebo group. After four weeks, the placebo group was allowed to crossover into the treatment group. The Neuropathic Pain Scale (NPS) was administered biweekly to assess the mean change from baseline to the end of the treatment period.

Conclusion: Our findings demonstrate that the transdermal application of CBD oil can achieve significant improvement in pain and other disturbing sensations in patients with peripheral neuropathy. The treatment product was well tolerated and may provide a more effective alternative compared to other current therapies in the treatment of peripheral neuropathy.

Results: The study population included 62.1% males and 37.9% females with a mean age of 68 years. There was a statistically significant reduction in intense pain, sharp pain, cold and itchy sensations in the CBD group when compared to the placebo group. No adverse events were reported in this study.

Background: Peripheral neuropathy can significantly impact the quality of life for those who are affected, as therapies from the current treatment algorithm often fail to deliver adequate symptom relief. There has, however, been an increasing body of evidence for the use of cannabinoids in the treatment of chronic, noncancer pain. The efficacy of a topically delivered cannabidiol (CBD) oil in the management of neuropathic pain was examined in this four-week, randomized and placebocontrolled trial.

Keywords: CBD; cannabis sativa; diabetic neuropathy; hemp; nerve pain; review..